BRANDL TALOS advises Climentum Capital on €4.5m seed financing round of Fermify

Press release • Corporate Law & Transactions from Roman Rericha, Stephan Strass

BRANDL TALOS has advised European ClimateTech fund Climentum Capital as lead investor on the €4.5 million seed financing round of Vienna-based Fermify GmbH.

Fermify is an Austrian FoodTech company that provides a solution for in-house production of casein proteins based on precision fermentation with the aim to reduce greenhouse gas emissions.

The funding round was led by Climentum Capital as lead investor besides Auxxo Female Catalyst Fund, Fund F, Clima Now, Satgana Ventures and Triple Impact Ventures. These join the existing pre-seed investors Übermorgen Ventures, Backbone Ventures, PUSH Ventures and Simon Capital, who also contributed to the funding.

The BRANDL TALOS team included Roman Rericha, Stephan Strass, Elena Ciresa and Céline Dobnikar.

The team

Roman Rericha

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 17
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 8
            [filter] => raw
        )

)

Partner / Fund Formation, Venture Capital & Start Ups, Corporate Law & Transactions

Roman represents clients in complex cross-border M&A and private equity transactions. Austrian and international venture capital funds regularly turn to him for assisting with investments in Austria. His expert advice also guides start-ups through large-scale financing rounds.

University of Vienna, Faculty of Law (Mag. iur. 2005),
Faculty of Business, Economics and Statistics, (Mag. rer.soc.oec. 2007)

Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 17
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 8
            [filter] => raw
        )

)

Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Latest insights into
Corporate Law & Transactions

BRANDL TALOS advised DirectSens on the sale of its market-leading LactoSens® biosensor technology to Kerry Group

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass

Founded in 2013 in Vienna by Christoph Sygmund, Roman Kittl, Roland Ludwig, Wolfgang Harreither and Alfons Felice as a spinoff of BOKU University, DirectSens specializes in developing biosensors, including LactoSens®, a rapid lactose detection tool. The acquisition of LactoSens® by Kerry Group reflects DirectSens' success in developing cutting-edge biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes.

BRANDL TALOS advises Tipico on Sale of U.S. Sportsbook and Online Casino Platform to MGM Resorts International

Press release • Corporate Law & Transactions from Thomas Talos, Stephan Strass, Daniel Habich

Tipico entered into an agreement to sell its U.S. sportsbook and casino platform to LeoVegas group, a subsidiary of MGM Resorts International (NYSE: MGM).

BRANDL TALOS advises Pride Capital Partners on the acquisition of a minority stake in RUBICON alongside RSM Ebner Stolz

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Adrian Zuschmann

Pride Capital Partners, with offices in Amsterdam, Cologne, and Copenhagen, is a hybrid private equity & debt investor focusing on the software and IT industry. With the acquisition of a minority stake in Vienna-based RUBICON Group, Pride completes its first Austrian investment.